Attached files
file | filename |
---|---|
EX-31.4 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AzurRx BioPharma, Inc. | azrx_314.htm |
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - AzurRx BioPharma, Inc. | azrx10ka_dec312017.htm |
Exhibit 31.3
CERTIFICATION PURSUANT TO RULE 13A-14 OF THE SECURITIES EXCHANGE
ACT OF 1934
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF
2002
I, Johan M. (Thijs) Spoor, Chief Executive Officer of
the Company, certify that:
1.
|
I have reviewed this Amendment No. 1 to the Annual Report on Form
10-K of AzurRx BioPharma, Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the
period covered by this report.
|
Date: April 27,
2018
|
/s/ Johan M. (Thijs) Spoor
Johan M. (Thijs) Spoor
Chief Executive Officer
(Principal Executive Officer)
|